Jupiter Neurosciences (JUNS) Net Shares Issued and Repurchased (2023 - 2025)
Jupiter Neurosciences' (JUNS) quarterly Net Shares Issued and Repurchased came in at $1.1 million in Q4 2025, up 267.58% year-over-year from $297105.0 in Q4 2024, and up 336.84% quarter-over-quarter from $250000.0 in Q2 2025.
Analysis
Jupiter Neurosciences (JUNS) Net Shares Issued and Repurchased (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Net Shares Issued and Repurchased for 3 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 267.58% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 267.58% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 267.58% from the prior year.
- Net Shares Issued and Repurchased was $1.1 million for Q4 2025 at Jupiter Neurosciences, up from $250000.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $3.8 million in Q4 2023 and troughed at $250000.0 in Q2 2025.
- A 3-year average of $1.4 million and a median of $694605.0 in 2024 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased plunged 92.11% in 2024 and surged 267.58% in 2025, its largest moves.
- Over 3 years, Net Shares Issued and Repurchased stood at $3.8 million in 2023, then sank by 92.11% to $297105.0 in 2024, then surged by 267.58% to $1.1 million in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $1.1 million (Q4 2025), $250000.0 (Q2 2025), and $297105.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.23 Bn | 68.86 Bn | 3.30 Bn | - |
| 2 | Kenvue | 34.13 Bn | 33.02 Bn | 2.30 Bn | - |
| 3 | Kimberly Clark | 32.73 Bn | 31.77 Bn | 1.60 Bn | - |
| 4 | Bath & Body Works | 3.77 Bn | 2.98 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.27 Bn | 2.21 Bn | - | - |
| 6 | Perrigo | 1.89 Bn | 1.49 Bn | 313.90 Mn | - |
| 7 | Herbalife | 1.28 Bn | 905.45 Mn | 1.03 Bn | - |
| 8 | Edgewell Personal Care | 1.24 Bn | 840.59 Mn | 242.50 Mn | - |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Jupiter Neurosciences | 1.75 Mn | 223,310.77 | 21,064.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.09 Mn |
| Jun 30, 2025 | 250,000.00 |
| Dec 31, 2024 | 297,105.00 |
| Dec 31, 2023 | 3.77 Mn |